Related Experiment Video

Updated: May 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K

Hepatitis C virus recurrence after liver transplantation

T Bizollon1, C Ducerf, C Trepo

  • 1Hepatology and Liver Transplantation Unit, Hôtel-Dieu Croix-Rousse, Lyon, France.

Gut
|March 17, 1999
PubMed

Insights

Hepatitis C virus (HCV) recurrence after liver transplant is common. Early treatment with interferon and ribavirin shows promise in preventing or delaying graft disease progression.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) cirrhosis is a leading reason for liver transplantation in Western countries.
  • Recurrent HCV infection post-transplant is nearly unavoidable without prophylaxis.
  • Factors influencing HCV recurrence and graft disease progression are not fully understood.

Purpose of the Study:

  • To evaluate the efficacy of early combination therapy for recurrent hepatitis C virus infection after liver transplantation.
  • To determine if interferon and ribavirin can prevent or slow HCV-related graft disease progression.

Main Methods:

  • Review of current literature on recurrent HCV post-liver transplant.
  • Analysis of outcomes for patients treated with interferon alone versus combination therapy.
  • Assessment of graft disease progression in relation to treatment strategies.

Main Results:

  • Interferon (IFN) monotherapy has been unsatisfactory for treating recurrent HCV.
  • Early intervention using a combination of IFN and ribavirin appears promising.
  • This combination therapy may offer a strategy to prevent or delay graft disease progression.

Conclusions:

  • Recurrent hepatitis C virus infection remains a significant challenge after liver transplantation.
  • Combination therapy with interferon and ribavirin is a potential therapeutic approach.
  • Further research is needed to optimize treatment and improve long-term outcomes for liver transplant recipients with HCV.

More Related Videos

Author Spotlight: Exploring Cold Ischemia and Warm Reperfusion Injury in Fatty Liver Transplantation05:25

Author Spotlight: Exploring Cold Ischemia and Warm Reperfusion Injury in Fatty Liver Transplantation

Published on: December 1, 2023

2.3K
A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.7K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25